Detection of residual disease and recurrence in early-stage non-small cell lung cancer (NSCLC) patients using sensitive personalized ctDNA sequencing assays.

Katrin Heider,Davina Gale,Giovanni Marsico,Andrea Ruiz-Valdepeñas,Garima Sharma,Malcolm Perry,Robert Osborne,Karen Howarth,Viona Rundell,Jelena Belic,Jerome Wulff,Susan Harden,Doris Rassl,Robert C. Rintoul,Nitzan Rosenfeld

Detection of residual disease and recurrence in early-stage non-small cell lung cancer (NSCLC) patients using sensitive personalized ctDNA sequencing assays.

2020

Katrin Heider
Davina Gale
Giovanni Marsico
Andrea Ruiz-Valdepeñas
Garima Sharma
Malcolm Perry
Robert Osborne
Karen Howarth
Viona Rundell
Jelena Belic
Jerome Wulff
Susan Harden
Doris Rassl
Robert C. Rintoul
Nitzan Rosenfeld

e15560Background: Detection of residual circulating tumour DNA (ctDNA) in patient plasma following curative intervention for localized non-small cell lung cancer (NSCLC) could identify patients who...

Keywords:

non small cell
Internal medicine
Oncology
Medicine
Disease
in patient
non-small cell lung cancer (NSCLC)
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations